Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To identify independent factors that may predict vesicoureteral reflux (VUR) resolution after endoscopic treatment using dextranomer/hyaluronic acid copolymer (Deflux®) in children free of anatomical anomalies.
Materials and methods
A retrospective study was conducted in our pediatric referral center from 1998 to 2011 on children with primary VUR who underwent endoscopic injection of Deflux® with or without concomitant autologous blood injection (called HABIT or HIT, respectively). Children with secondary VUR or incomplete records were excluded from the study. Potential factors were divided into three categories including preoperative, intraoperative and postoperative. Success was defined as no sign of VUR on postoperative voiding cystourethrogram. Univariate and multivariate logistic regression models were constructed to identify independent factors that may predict success. Odds ratio (OR) and 95 % confidence interval (95 % CI) for prediction of success were estimated for each factor.
From 485 children received Deflux® injection, a total of 372 with a mean age of 3.10 years (ranged from 6 months to 12 years) were included in the study and endoscopic management was successful in 322 (86.6 %) of them. Of the patients, 185 (49.7 %) underwent HIT and 187 (50.3 %) underwent HABIT technique. On univariate analysis, VUR grade from preoperative category (OR = 4.79, 95 % CI = 2.22–10.30, p = 0.000), operation technique (OR = 0.33, 95 % CI = 0.17–0.64, p = 0.001) and presence of mound on postoperative sonography (OR = 0.06, 95 % CI = 0.02–0.16, p = 0.000) were associated with success. On multivariate analysis, preoperative VUR grade (OR = 4.85, 95 % CI = 2.49–8.96, p = 0.000) and identification of mound on postoperative sonography (OR = 0.07, 95 % CI = 0.01–0.18, p = 0.000) remained as independent success predictors.
Based on this study, successful VUR correction after the endoscopic injection of Deflux® can be predicted with respect to preoperative VUR grade and presence of mound after operation.
- Jacobson, SH, Hansson, S, Jakobsson, B (1999) Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr Suppl 88: pp. 22-30 CrossRef
- Peters, CA, Skoog, SJ, Arant, BS, Copp, HL, Elder, JS, Hudson, RG, Khoury, AE, Lorenzo, AJ, Pohl, HG, Shapiro, E, Snodgrass, WT, Diaz, M (2010) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184: pp. 1134-1144 CrossRef
- Diamond, DA, Mattoo, TK (2012) Endoscopic treatment of primary vesicoureteral reflux. N Engl J Med 366: pp. 1218-1226 CrossRef
- Elder, JS, Diaz, M, Caldamone, AA, Cendron, M, Greenfield, S, Hurwitz, R, Kirsch, A, Koyle, MA, Pope, J, Shapiro, E (2006) Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175: pp. 716-722 CrossRef
- Kajbafzadeh, AM, Tourchi, A (2012) Usefulness of concomitant autologous blood and dextranomer/hyaluronic acid copolymer injection to correct vesicoureteral reflux. J Urol.
- Routh, JC, Reinberg, Y (2010) Predicting success in the endoscopic management of pediatric vesicoureteral reflux. Urology 76: pp. 195-198 CrossRef
- Lebowitz, RL, Olbing, H, Parkkulainen, KV, Smellie, JM, Tamminen-Mobius, TE (1985) International system of radiographic grading of vesicoureteric reflux. International Reflux Study in children. Pediatr Radiol 15: pp. 105-109 CrossRef
- O’Donnell, B, Puri, P (1984) Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J (Clin Res Ed) 289: pp. 7-9 CrossRef
- Chertin, B, Kocherov, S (2010) Long-term results of endoscopic treatment of vesicoureteric reflux with different tissue-augmenting substances. J Pediatr Urol 6: pp. 251-256 CrossRef
- Molitierno, JA, Scherz, HC, Kirsch, AJ (2008) Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. J Pediatr Urol 4: pp. 221-228 CrossRef
- Kalisvaart, JF, Scherz, HC, Cuda, S, Kaye, JD, Kirsch, AJ (2011) Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesico-ureteral reflux. J Pediatr Urol.
- Stenberg, AM, Sundin, A, Larsson, BS, Lackgren, G, Stenberg, A (1997) Lack of distant migration after injection of a 125 iodine labeled dextranomer based implant into the rabbit bladder. J Urol 158: pp. 1937-1941 CrossRef
- Kirsch, A, Hensle, T, Scherz, H, Koyle, M (2006) Injection therapy: advancing the treatment of vesicoureteral reflux. J Pediatr Urol 2: pp. 539-544 CrossRef
- Kobelt G, Canning DA, Hensle TW, Lackgren G (2003) The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 169(4):1480–1484; discussion 1484–1485. doi:10.1097/01.ju.0000056638.75652.54S0022-5347(05)63798-6
- Tekgul, S, Riedmiller, H, Hoebeke, P, Kocvara, R, Nijman, RJ, Radmayr, C, Stein, R, Dogan, HS (2012) EAU guidelines on vesicoureteral reflux in children. Eur Urol.
- Lackgren, G, Stenberg, A (2009) Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment. Ther Adv Urol 1: pp. 131-141 CrossRef
- Dave S, Lorenzo AJ, Khoury AE, Braga LH, Skeldon SJ, Suoub M, Farhat W, Pippi Salle JL, Bagli DJ (2008) Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer. J Urol 180(4 Suppl):1594–1599; discussion 1599–1600. doi:10.1016/j.juro.2008.03.084
- Lorenzo, AJ, Pippi Salle, JL, Barroso, U, Cook, A, Grober, E, Wallis, MC, Bagli, DJ, Khoury, AE (2006) What are the most powerful determinants of endoscopic vesicoureteral reflux correction? Multivariate analysis of a single institution experience during 6 years. J Urol 176: pp. 1851-1855 CrossRef
- Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E (2006) Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176 (4 Pt 2):1856–1859; discussion 1859–1860. doi:10.1016/j.juro.2006.03.124
- Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA (2007) Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol 178(4 Pt 2):1702–1705; discussion 1705–1706. doi:10.1016/j.juro.2007.03.174
- Yucel, S, Gupta, A, Snodgrass, W (2007) Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 177: pp. 1505-1509 CrossRef
- Kirsch, AJ, Perez-Brayfield, MR, Scherz, HC (2003) Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children’s Hospitals of Atlanta experience. J Urol 170: pp. 211-215 CrossRef
- Lavelle, MT, Conlin, MJ, Skoog, SJ (2005) Subureteral injection of Deflux for correction of reflux: analysis of factors predicting success. Urology 65: pp. 564-567 CrossRef
- Serrano-Durba, A, Serrano, AJ, Magdalena, JR, Martin, JD, Soria, E, Dominguez, C, Estornell, F, Garcia-Ibarra, F (2004) The use of neural networks for predicting the result of endoscopic treatment for vesico-ureteric reflux. BJU Int 94: pp. 120-122 CrossRef
- Lackgren G, Skoldenberg E, Stenberg A (2007) Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 177(3):1124–1128; discussion 1128–1129. doi:10.1016/j.juro.2006.10.094
- Molitierno, JA, Scherz, HC, Kirsch, AJ (2008) Endoscopic injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters. J Pediatr Urol 4: pp. 372-376 CrossRef
- Cerwinka, WH, Scherz, HC, Kirsch, AJ (2007) Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. J Urol 178: pp. 1469-1473 CrossRef
- Bar-Yosef, Y, Castellan, M, Joshi, D, Labbie, A, Gosalbez, R (2011) Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates. J Urol 185: pp. 2531-2534 CrossRef
- Ben-Meir, D, Morgenstern, S, Sivan, B, Efrat, R, Livne, PM (2012) Histology proved malpositioning of dextranomer/hyaluronic Acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. J Urol 188: pp. 258-261 CrossRef
- Ellsworth, PI, Yates, JK, Caldamone, AA (2011) Presence of dextranomer-hyaluronic acid (DxHA) mound on postoperative ultrasound does not predict resolution of vesicoureteral reflux. J Pediatr Urol 7: pp. 438-440 CrossRef
- Factors that impact the outcome of endoscopic correction of vesicoureteral reflux: a multivariate analysis
International Urology and Nephrology
Volume 45, Issue 1 , pp 1-9
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Vesicoureteral reflux
- Bulking agent
- Industry Sectors